The need for optimal crossover in trials testing the anticipation of treatments: A methodological and ethical issue

The need for optimal crossover in trials testing the anticipation of treatments: A methodological and ethical issue

Quality of control arms in randomized clinical trials implies also optimal postprotocol treatment. Meta‐research studies highlighting biases of the published literature contribute to improving design and conduct of future studies.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer 2024-08, Vol.130 (16), p.2743-2745
1. Verfasser: Di Maio, Massimo
Format: Artikel
Sprache:eng
Schlagworte:
Clinical trials
Clinical Trials as Topic - ethics
Cross-Over Studies
Humans
Research Design - standards
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Quality of control arms in randomized clinical trials implies also optimal postprotocol treatment. Meta‐research studies highlighting biases of the published literature contribute to improving design and conduct of future studies.
ISSN:0008-543X
1097-0142
1097-0142
DOI:10.1002/cncr.35370